Phenoxybenzamine hydrochloride

This classification denotes an adrenergic alpha-antagonist, antihypertensive agent, and vasodilator agent with the molecular formula C18H22ClNO.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X1IEG24OHL, chemically known as n-(2-chloroethyl)-n-(1-methyl-2-phenoxyethyl)benzylamine, hydrochloride but more generally known as phenoxybenzamine hydrochloride, which bears US NIH Compound Identifier 4768. European Medicines Agency schedules Phenoxybenzamine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03761MIG. Most nations, for tariff and trade purposes, schedule phenoxybenzamine hydrochloride under HS 29221980 and SITC 51461. As of Q4 2014, PHENOXYBENZAMINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Phenoxybenzamine hydrochloride bears US NLM identifiers UMLS ID C0701367 and NCI Concept Code C44435. SMILES: CC(COC1CCCCC1)N(CCCL)CC2CCCCC2.CL.